Document is current
Any future updates will be listed below
-
Authors
Sasaki, Lena
Hamada, Yuki
Yarimizu, Daisuke
Suzuki, Tomo
Nakamura, Hiroki
Shimada, Aya
Pham, Khanh Tien Nguyen
Shao, Xinyan
Yamamura, Koki
Inatomi, Tsutomu
Morinaga, Hironobu
Nishimura, Emi K. https://orcid.org/0000-0002-5767-8045
Kudo, Fujimi
Manabe, Ichiro https://orcid.org/0000-0001-9481-6673
Haraguchi, Shogo https://orcid.org/0000-0002-8731-3311
Sugiura, Yuki
Suematsu, Makoto https://orcid.org/0000-0002-7165-6336
Kinoshita, Shigeru
Machida, Mamiko
Nakajima, Takeshi
Kiyonari, Hiroshi https://orcid.org/0000-0002-1509-8747
Okamura, Hitoshi
Yamaguchi, Yoshiaki
Miyake, Takahito https://orcid.org/0000-0002-4356-5883
Doi, Masao https://orcid.org/0000-0001-6264-9217
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21gm5010002)
Ministry of Education, Culture, Sports, Science and Technology (18H04015, 20B307)
- License Information
-
More Information
Article History
Received: 3 April 2021
Accepted: 22 December 2021
First Online: 10 February 2022
Competing interests
: M.D., T.N. and M.M. have filed a patent application related to the new uses of NMN and NR (WO2020262497). M.D., T.S. and S.K. received institutional research funding from Senju Pharmaceutical Co. T.N. and M.M. are employees of Senju Pharmaceutical Co. All other authors declare no competing interests.
